Degree of Planning of Sexual Intercourse Among Men From China, Japan, and Taiwan Taking Medication for Erectile Dysfunction: Findings of an Observational, Cross-Sectional Survey-Reference-Cited by-同舟云学术

Degree of Planning of Sexual Intercourse Among Men From China, Japan, and Taiwan Taking Medication for Erectile Dysfunction: Findings of an Observational, Cross-Sectional Survey

Published:2019-03 Issue:1 Volume:7 Page:54-60
ISSN:2050-1161
Container-title:Sexual Medicine
language:en
Short-container-title:Sexual Medicine

Author:

Jiann Bang-Ping,Nakajima Koichi,Dighe Sonali,Harshman-Smith Chad D.,Hassan Tarek A.

Funder

Pfizer Inc.

Publisher

Elsevier BV

Subject

Behavioral Neuroscience,Urology,Dermatology,Reproductive Medicine,Endocrinology,Endocrinology, Diabetes and Metabolism,Psychiatry and Mental health

Reference22 articles.

1. PDE5 inhibitors: Considerations for preference and long-term adherence;Smith;Int J Clin Pract,2013

2. The wonders of phosphodiesterase-5 inhibitors: A majestic history;Elhwuegi;Ann Med Health Sci Res,2016

3. Daily patterns of sexual intercourse attempts by men with erectile dysfunction treated with tadalafil: Influence of age and marital status;Shabsigh;Int J Impot Res,2009

4. Sexual life of Japanese patients with erectile dysfunction taking phosphodiesterase type 5 inhibitors: An internet survey using the Psychological and Interpersonal Relationship Scales-Short Form questionnaire;Tsujimura;Int J Urol,2014

5. Therapeutic effectiveness and patient satisfaction after 6 months of treatment with tadalafil, sildenafil, and vardenafil: Results from the Erectile Dysfunction Observational Study (EDOS);Martin-Morales;Eur Urol,2007

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacokinetics comparison of vardenafil as administered by an intranasal spray formulation vs a 10-mg oral tablet;The Journal of Sexual Medicine;2023-05-04

2. Real-World Assessment of the Impact of Erectile Dysfunction on Sexual Planning Behavior and Health- and Treatment-Related Outcomes Among Men in 8 Countries;Sexual Medicine;2020-09

3. The first‐generation phosphodiesterase 5 inhibitors and their pharmacokinetic issue;Andrology;2019-07-26